Nirrin Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $6.7M

  • Investors
  • 5

Nirrin General Information

Description

Developer of a noninfectious bioprocess monitoring technology designed to deliver improved process control, faster processes, and adaptive manufacturing. The company's technology leverages innovative chemometric methods and application-specific knowledge, providing real-time analysis of glucose, lactate, Total Cell Density (TCD), Viable Cell Density (VCD), and proteins, enabling pharmaceutical companies to improve process control and develop medicines faster and more cost-effectively.

Contact Information

Website
www.nirrin.tech
Formerly Known As
Nirrin Biopress Analytics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 44 Manning Road
  • Billerica, MA 01821
  • United States
+1 (508)
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 44 Manning Road
  • Billerica, MA 01821
  • United States
+1 (508)

Nirrin Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nirrin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 15-Jun-2026 $6.7M Completed Generating Revenue
6. Accelerator/Incubator 10-Jun-2025 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
4. Grant 04-Sep-2024 Completed Generating Revenue
3. Later Stage VC (Series A) 13-Feb-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Oct-2021 $8.5M $17M Completed Generating Revenue
1. Seed Round 05-May-2020 $8.5M $8.5M Completed Startup
To view Nirrin’s complete valuation and funding history, request access »

Nirrin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A 2,771,846 $0.000100 8% $7.68 $7.68 1x $7.68 25.73%
Seed 3,000,656 $0.000100 8% $1.67 $1.67 1x $1.67 27.85%
To view Nirrin’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nirrin Patents

Nirrin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260358307-A1 Tandem hplc and nir spectroscopy system and method for monitoring bioprocesses Pending 12-May-2025
WO-2026169697-A1 In-line flow cell for monitoring bioprocesses Pending 07-Feb-2025
WO-2026164951-A1 Filtration system control based on spectroscopic analysis including sterile filtration Pending 30-Jan-2025
WO-2025165726-A1 Biologic characterization Pending 29-Jan-2024
WO-2025147640-A1 Systems and methods for wavelength and intensity referencing Inactive 04-Jan-2024 G01J3/26
To view Nirrin’s complete patent history, request access »

Nirrin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nirrin Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTools Innovator Accelerator/Incubator
MedTech Innovator Accelerator/Incubator
National Institutes of Health Government
Anzu Partners Venture Capital Minority
Gamma Biosciences PE-Backed Company Minority
To view Nirrin’s complete investors history, request access »

Nirrin FAQs

  • When was Nirrin founded?

    Nirrin was founded in 2018.

  • Where is Nirrin headquartered?

    Nirrin is headquartered in Billerica, MA.

  • What is the size of Nirrin?

    Nirrin has 21 total employees.

  • What industry is Nirrin in?

    Nirrin’s primary industry is Biotechnology.

  • Is Nirrin a private or public company?

    Nirrin is a Private company.

  • What is the current valuation of Nirrin?

    The current valuation of Nirrin is .

  • What is Nirrin’s current revenue?

    The current revenue for Nirrin is .

  • How much funding has Nirrin raised over time?

    Nirrin has raised $28.5M.

  • Who are Nirrin’s investors?

    BioTools Innovator, MedTech Innovator, National Institutes of Health, Anzu Partners, and Gamma Biosciences have invested in Nirrin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process